Literature DB >> 31119280

Change in Plasma Cryptococcal Antigen Titer Is Not Associated With Survival Among Human Immunodeficiency Virus-infected Persons Receiving Preemptive Therapy for Asymptomatic Cryptococcal Antigenemia.

Matthew F Pullen1, Francis Kakooza2, Elizabeth Nalintya2, Agnes N Kiragga2, Bozena M Morawski1, Radha Rajasingham1, Anthony Mubiru3, Yukari C Manabe4, Jonathan E Kaplan3, David B Meya1,2,5, David R Boulware1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31119280      PMCID： PMC6938973          DOI： 10.1093/cid/ciz418

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease.

Authors:  J A Aberg; J Watson; M Segal; L W Chang
Journal:  HIV Clin Trials       Date:  2000 Jul-Aug

2.  Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid.

Authors:  Taseera Kabanda; Mark J Siedner; Jeffrey D Klausner; Conrad Muzoora; David R Boulware
Journal:  Clin Infect Dis       Date:  2013-09-24       Impact factor: 9.079

3.  Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.

Authors:  Sayoki Mfinanga; Duncan Chanda; Sokoine L Kivuyo; Lorna Guinness; Christian Bottomley; Victoria Simms; Carol Chijoka; Ayubu Masasi; Godfather Kimaro; Bernard Ngowi; Amos Kahwa; Peter Mwaba; Thomas S Harrison; Saidi Egwaga; Shabbar Jaffar
Journal:  Lancet       Date:  2015-03-10       Impact factor: 79.321

Review 4.  Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing.

Authors:  Radha Rajasingham; Rachel M Wake; Tafese Beyene; Andrew Katende; Emilio Letang; David R Boulware
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

5.  Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized Trial.

Authors:  David B Meya; Agnes N Kiragga; Elizabeth Nalintya; Bozena M Morawski; Radha Rajasingham; Benjamin J Park; Anthony Mubiru; Jonathan E Kaplan; Yukari C Manabe; David R Boulware
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731
  5 in total
  1 in total

1.  Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update.

Authors:  Nelesh P Govender; Graeme Meintjes; Phetho Mangena; Jeremy Nel; Samantha Potgieter; Denasha Reddy; Helena Rabie; Douglas Wilson; John Black; David Boulware; Tom Boyles; Tom Chiller; Halima Dawood; Sipho Dlamini; Thomas S Harrison; Prudence Ive; Joseph Jarvis; Alan Karstaedt; Matamela C Madua; Colin Menezes; Mahomed-Yunus S Moosa; Zaaheera Motlekar; Amir Shroufi; Sarah Lynn Stacey; Merika Tsitsi; Gilles van Cutsem; Ebrahim Variava; Michelle Venter; Rachel Wake
Journal:  South Afr J HIV Med       Date:  2019-11-08       Impact factor: 2.744
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.